FDA approves RedHill antibiotic drug Talicia for treatment of adult patients infected with Helicobacter pylori
-
Last Update: 2020-06-07
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
recently,(http://of bio
pharmaceutical(http:// announced that its http://of the antibioticdrug was approved for thefda(http://to treat adult patients infected with Helicobacter pyloriRedHill's share stake on the Tel Aviv Stock Exchange rose more than 13 percent after Talicia's approvalIn addition, the company received a $59 million strategic investment from Cosmo PharmaceuticalsTalicia is the first FDA-approved three-in-one oral capsule based on the antibiotic rifabutinRedHill released the results of Talicia's Phase III TestTrial(http://in December 2018, which showed that the drug had an 84% eradication rate against Helicobacter pylori and that the bacteria did not show resistance About RedHill
RedHill, a biopharmaceutical company founded in 2009, is a leading patent (http:// drugs on the market The company has an experienced management team headquartered in Tel Aviv, Israel, and has a business operations headquarters in North Carolina, USA in addition to Talicia, RedHill will continue to develop new gastric disease treatments to meet the needs of patients medical (http://
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
